Home » Topics » BioWorld Science

BioWorld Science
RSS

Neurex and Beaufour Ipsen reach licensing agreement for Corlopam

Oct. 11, 1996

Wakunaga discloses angiotensin II antagonists

Oct. 11, 1996

Endothelin antagonists from Banyu

Oct. 11, 1996

Warner-Lambert claims endothelin antagonists

Oct. 11, 1996

Respiratory drugs in Fujisawa's product pipeline

Oct. 11, 1996

Respiratory R&D at Yamanouchi

Oct. 11, 1996

Approval of Pulmozyme recommended for new indication

Oct. 11, 1996

Treatment for cystic fibrosis patients progresses on schedule

Oct. 11, 1996

Dual thromboxane synthase/lipoxygenase inhibitors from Nikken Chemicals

Oct. 11, 1996

New antihistamine for pediatric patients in the U.S.

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...